Pfizer shares jumped 4% Wednesday after it released positive results from its closely watched early stage human trial of a coronavirus vaccine. The trial evaluated 45 people. Each participant received 10, 30 or 100 microgram doses of the vaccine or a placebo. The company…
Read More...Browsing Category
Finance
Kia unveils new K5 in attempt to halt skidding sedan sales
Kia Motors isn't giving up on the midsize sedan segment despite significant sales declines as U.S. consumers…
Micron, Xilinx, Lululemon, Boeing, Uber and more
Micron Technology's hard drive for data center customers is presented at a product launch event in San…
Facebook boycott: Clorox pull ads through to end of the year
Clorox has joined the growing list of brands to have pulled its advertisements from Facebook in a protest over…